Carlo Farina

Discovery of a Novel Antitumor Benzolactone Enamide Class That Selectively Inhibits Mammalian Vacuolar-Type (H+)-ATPases

Michael R. Boyd, Carlo Farina, Pietro Belfiore et al. · Journal of Pharmacology and Experimental Therapeutics · 2001 · 142 citations

A selective inhibitor of the osteoclastic V-H+-ATPase prevents bone loss in both thyroparathyroidectomized and ovariectomized rats

L. Visentin, Robert A. Dodds, Maurizio Valente et al. · Journal of Clinical Investigation · 2000 · 129 citations · Full text

Percutaneous transluminal angioplasty versus surgery for subclavian artery occlusive disease

Carlo Farina, Andrea Mingoli, Richard D. Schultz et al. · The American Journal of Surgery · 1989 · 109 citations

Endovascular Technique, Vascular Surgery, Thoracic Surgery +4

Elevated levels of a C-terminal agrin fragment identifies a new subset of sarcopenia patients

Stefan Hettwer, Pius Dahinden, Stefan Kucsera et al. · Experimental Gerontology · 2012 · 104 citations · Full text

C-terminal Agrin Fragment, Clinical Physiology, Elevated Levels +14

Discovery of a Novel Class of Selective Non-Peptide Antagonists for the Human Neurokinin-3 Receptor. 1. Identification of the 4-Quinolinecarboxamide Framework

Giuseppe Giardina, Henry M. Sarau, Carlo Farina et al. · Journal of Medicinal Chemistry · 1997 · 79 citations · Full text

4-Quinolinecarboxamide Framework, Receptor Antagonists, Pharmacotherapy +18